webleads-tracker

Pharma Compliance Info SocialVigilance | Searching social networks to detect adverse reactions Pharmacovigilance

SocialVigilance | Searching social networks to detect adverse reactions

Regulators and pharmaceutical companies are monitoring social media posts for potential adverse drug reaction signals.
Up to 90% of side effects to drugs are not reported, according to some estimates. “Adverse drug reactions (ADRs) are grossly under reported by everyone, including healthcare professionals, but particularly so by patients,” says David Lewis, head of global safety at Novartis, who is co-ordinating the involvement of pharmaceutical companies in a €2.3m three-year public-private project called Web-RADR (Recognising Adverse Drug Reactions).
Data from the European Medicines Agency (EMA) indicate that patients are not reporting side effects adequately through official channels and several regulators are exploring the possibility of making use of the abundant information swirling around social networks.
To read the article by Elizabeth Sukkar, MRPharmS, deputy news editor of The Pharmaceutical Journal

Check Also

Pharma Compliance Info Conclusions de la mission "Flash" sur le scandale du Levothyrox auprès de l'Assemblée nationale. Pharmacovigilance

Conclusions de la mission “Flash” sur le scandale du Levothyrox auprès de l’Assemblée nationale.

Mardi dernier, le médecin et député Jean-Pierre Door a rendu les conclusions de sa mission …

X